Share Price and Basic Stock Data
Last Updated: June 4, 2025, 8:06 pm
PEG Ratio | 0.28 |
---|
Competitors of Kingfa Science & Technology (India) Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Mitsu Chem Plast Ltd | 158 Cr. | 116 | 164/83.2 | 21.8 | 71.4 | 0.17 % | 10.4 % | 8.22 % | 10.0 |
IIRM Holdings India Ltd | 552 Cr. | 81.0 | 172/27.8 | 24.6 | 19.4 | 0.00 % | 23.5 % | 18.6 % | 5.00 |
Fiberweb (India) Ltd | 150 Cr. | 52.3 | 66.6/34.0 | 10.0 | 61.2 | 0.00 % | 10.0 % | 8.88 % | 10.0 |
Deep Polymers Ltd | 121 Cr. | 50.0 | 93.1/35.7 | 23.4 | 36.2 | 0.00 % | 8.22 % | 6.08 % | 10.0 |
DDev Plastiks Industries Ltd | 2,859 Cr. | 277 | 458/213 | 15.4 | 80.7 | 0.54 % | 33.8 % | 24.8 % | 1.00 |
Industry Average | 1,420.69 Cr | 426.67 | 38.68 | 157.26 | 0.22% | 16.41% | 12.42% | 8.25 |
All Competitor Stocks of Kingfa Science & Technology (India) Ltd
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 304 | 346 | 351 | 340 | 366 | 339 | 351 | 394 | 404 | 416 | 418 | 440 | 470 |
Expenses | 287 | 338 | 317 | 310 | 311 | 289 | 306 | 356 | 354 | 359 | 362 | 389 | 409 |
Operating Profit | 17 | 8 | 34 | 31 | 55 | 50 | 45 | 38 | 51 | 57 | 56 | 51 | 60 |
OPM % | 6% | 2% | 10% | 9% | 15% | 15% | 13% | 10% | 13% | 14% | 13% | 12% | 13% |
Other Income | -6 | 0 | 1 | 1 | 1 | 2 | 0 | 1 | 2 | 2 | 1 | 5 | 2 |
Interest | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 |
Depreciation | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 6 |
Profit before tax | 5 | 3 | 30 | 27 | 49 | 47 | 40 | 32 | 45 | 52 | 50 | 49 | 54 |
Tax % | 27% | 27% | 26% | 25% | 26% | 25% | 25% | 25% | 26% | 25% | 26% | 30% | 23% |
Net Profit | 4 | 2 | 22 | 20 | 37 | 35 | 30 | 24 | 34 | 39 | 37 | 35 | 42 |
EPS in Rs | 3.30 | 2.04 | 18.24 | 16.70 | 30.24 | 28.93 | 24.44 | 20.09 | 27.70 | 32.26 | 30.77 | 28.60 | 34.60 |
Last Updated: May 31, 2025, 8:40 am
Below is a detailed analysis of the quarterly data for Kingfa Science & Technology (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 470.00 Cr.. The value appears strong and on an upward trend. It has increased from 440.00 Cr. (Dec 2024) to 470.00 Cr., marking an increase of 30.00 Cr..
- For Expenses, as of Mar 2025, the value is 409.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 389.00 Cr. (Dec 2024) to 409.00 Cr., marking an increase of 20.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Dec 2024) to 60.00 Cr., marking an increase of 9.00 Cr..
- For OPM %, as of Mar 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 12.00% (Dec 2024) to 13.00%, marking an increase of 1.00%.
- For Other Income, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Dec 2024) to 2.00 Cr., marking a decrease of 3.00 Cr..
- For Interest, as of Mar 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Dec 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5.00 Cr. (Dec 2024) to 6.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 54.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Dec 2024) to 54.00 Cr., marking an increase of 5.00 Cr..
- For Tax %, as of Mar 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Dec 2024) to 23.00%, marking a decrease of 7.00%.
- For Net Profit, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Dec 2024) to 42.00 Cr., marking an increase of 7.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 34.60. The value appears strong and on an upward trend. It has increased from 28.60 (Dec 2024) to 34.60, marking an increase of 6.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 6:08 am
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 157 | 178 | 219 | 314 | 427 | 602 | 702 | 742 | 627 | 1,048 | 1,404 | 1,488 | 1,680 |
Expenses | 155 | 181 | 212 | 288 | 408 | 560 | 666 | 698 | 607 | 966 | 1,276 | 1,303 | 1,464 |
Operating Profit | 2 | -3 | 6 | 27 | 19 | 41 | 35 | 43 | 20 | 82 | 128 | 185 | 216 |
OPM % | 1% | -2% | 3% | 8% | 5% | 7% | 5% | 6% | 3% | 8% | 9% | 12% | 13% |
Other Income | 1 | 0 | 0 | 1 | 4 | 6 | 4 | 3 | 6 | -22 | 2 | 3 | 9 |
Interest | 7 | 7 | 8 | 7 | 2 | 2 | 2 | 4 | 3 | 5 | 7 | 6 | 6 |
Depreciation | 3 | 3 | 3 | 3 | 3 | 6 | 8 | 9 | 11 | 13 | 14 | 18 | 22 |
Profit before tax | -7 | -12 | -5 | 17 | 18 | 39 | 29 | 33 | 12 | 41 | 110 | 164 | 197 |
Tax % | -29% | -31% | -35% | 38% | 30% | 36% | 35% | 26% | 55% | 26% | 26% | 25% | |
Net Profit | -5 | -8 | -3 | 11 | 12 | 25 | 19 | 25 | 5 | 31 | 81 | 123 | 145 |
EPS in Rs | -4.14 | -6.95 | -2.49 | 8.93 | 10.24 | 20.35 | 15.74 | 20.33 | 4.39 | 25.29 | 67.22 | 101.17 | 119.33 |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 10% |
YoY Net Profit Growth
Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -60.00% | 62.50% | 466.67% | 9.09% | 108.33% | -24.00% | 31.58% | -80.00% | 520.00% | 161.29% | 51.85% |
Change in YoY Net Profit Growth (%) | 0.00% | 122.50% | 404.17% | -457.58% | 99.24% | -132.33% | 55.58% | -111.58% | 600.00% | -358.71% | -109.44% |
Kingfa Science & Technology (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 23% |
5 Years: | 19% |
3 Years: | 19% |
TTM: | 17% |
Compounded Profit Growth | |
---|---|
10 Years: | 48% |
5 Years: | 44% |
3 Years: | 48% |
TTM: | 25% |
Stock Price CAGR | |
---|---|
10 Years: | 35% |
5 Years: | 50% |
3 Years: | 52% |
1 Year: | 79% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 18% |
3 Years: | 22% |
Last Year: | 23% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 9:31 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 6 | 6 | 10 | 10 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Reserves | 13 | 5 | 2 | 109 | 234 | 293 | 312 | 336 | 342 | 372 | 454 | 576 | 641 |
Borrowings | 34 | 62 | 75 | 16 | 42 | 21 | 17 | 46 | 71 | 46 | 42 | 33 | 46 |
Other Liabilities | 31 | 31 | 41 | 95 | 119 | 159 | 210 | 202 | 246 | 449 | 502 | 373 | 364 |
Total Liabilities | 85 | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,063 |
Fixed Assets | 26 | 24 | 25 | 29 | 76 | 88 | 85 | 107 | 129 | 126 | 123 | 252 | 245 |
CWIP | 0 | 0 | 1 | 41 | 10 | 2 | 79 | 115 | 123 | 127 | 131 | 2 | 10 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Assets | 58 | 81 | 99 | 160 | 319 | 395 | 388 | 375 | 419 | 627 | 756 | 740 | 808 |
Total Assets | 85 | 105 | 125 | 230 | 405 | 485 | 551 | 596 | 671 | 880 | 1,010 | 994 | 1,063 |
Below is a detailed analysis of the balance sheet data for Kingfa Science & Technology (India) Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 12.00 Cr..
- For Reserves, as of Sep 2024, the value is 641.00 Cr.. The value appears strong and on an upward trend. It has increased from 576.00 Cr. (Mar 2024) to 641.00 Cr., marking an increase of 65.00 Cr..
- For Borrowings, as of Sep 2024, the value is 46.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 33.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 13.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is 364.00 Cr.. The value appears to be improving (decreasing). It has decreased from 373.00 Cr. (Mar 2024) to 364.00 Cr., marking a decrease of 9.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is 1,063.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 994.00 Cr. (Mar 2024) to 1,063.00 Cr., marking an increase of 69.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is 245.00 Cr.. The value appears to be declining and may need further review. It has decreased from 252.00 Cr. (Mar 2024) to 245.00 Cr., marking a decrease of 7.00 Cr..
- For CWIP, as of Sep 2024, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 8.00 Cr..
- For Investments, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2024, the value is 808.00 Cr.. The value appears strong and on an upward trend. It has increased from 740.00 Cr. (Mar 2024) to 808.00 Cr., marking an increase of 68.00 Cr..
- For Total Assets, as of Sep 2024, the value is 1,063.00 Cr.. The value appears strong and on an upward trend. It has increased from 994.00 Cr. (Mar 2024) to 1,063.00 Cr., marking an increase of 69.00 Cr..
Notably, the Reserves (641.00 Cr.) exceed the Borrowings (46.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -32.00 | -65.00 | -69.00 | 11.00 | -23.00 | 20.00 | 18.00 | -3.00 | -51.00 | 36.00 | 86.00 | 152.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 78 | 97 | 93 | 99 | 111 | 110 | 109 | 97 | 123 | 99 | 93 | 99 |
Inventory Days | 52 | 54 | 64 | 85 | 69 | 85 | 63 | 67 | 100 | 110 | 94 | 76 |
Days Payable | 68 | 66 | 72 | 127 | 108 | 108 | 119 | 115 | 152 | 181 | 155 | 110 |
Cash Conversion Cycle | 62 | 85 | 85 | 57 | 72 | 86 | 53 | 49 | 71 | 28 | 32 | 66 |
Working Capital Days | 57 | 90 | 87 | 66 | 82 | 99 | 59 | 69 | 82 | 48 | 56 | 86 |
ROCE % | -1% | -9% | 4% | 22% | 9% | 13% | 9% | 10% | 4% | 16% | 25% | 30% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 101.17 | 67.22 | 25.29 | 4.39 | 20.33 |
Diluted EPS (Rs.) | 101.17 | 67.22 | 25.29 | 4.39 | 20.33 |
Cash EPS (Rs.) | 116.35 | 78.90 | 36.00 | 13.31 | 27.72 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 486.00 | 384.78 | 317.57 | 292.29 | 287.84 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 486.00 | 384.78 | 317.57 | 292.29 | 287.84 |
Dividend / Share (Rs.) | 10.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue From Operations / Share (Rs.) | 1228.45 | 1159.08 | 865.13 | 517.93 | 612.28 |
PBDIT / Share (Rs.) | 155.39 | 107.56 | 68.41 | 21.43 | 37.86 |
PBIT / Share (Rs.) | 140.21 | 95.89 | 57.70 | 12.52 | 30.46 |
PBT / Share (Rs.) | 135.58 | 90.49 | 34.14 | 9.79 | 27.53 |
Net Profit / Share (Rs.) | 101.17 | 67.22 | 25.29 | 4.39 | 20.33 |
PBDIT Margin (%) | 12.64 | 9.27 | 7.90 | 4.13 | 6.18 |
PBIT Margin (%) | 11.41 | 8.27 | 6.66 | 2.41 | 4.97 |
PBT Margin (%) | 11.03 | 7.80 | 3.94 | 1.88 | 4.49 |
Net Profit Margin (%) | 8.23 | 5.79 | 2.92 | 0.84 | 3.31 |
Return on Networth / Equity (%) | 20.81 | 17.47 | 7.96 | 1.50 | 7.06 |
Return on Capital Employeed (%) | 28.66 | 24.65 | 17.08 | 3.92 | 9.99 |
Return On Assets (%) | 12.32 | 8.05 | 3.49 | 0.79 | 4.12 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.04 | 0.06 | 0.05 |
Total Debt / Equity (X) | 0.05 | 0.08 | 0.10 | 0.11 | 0.12 |
Asset Turnover Ratio (%) | 1.48 | 1.49 | 1.35 | 0.98 | 1.29 |
Current Ratio (X) | 1.80 | 1.37 | 1.30 | 1.45 | 1.59 |
Quick Ratio (X) | 1.20 | 0.83 | 0.74 | 0.94 | 1.10 |
Inventory Turnover Ratio (X) | 4.11 | 3.84 | 4.47 | 4.03 | 5.42 |
Interest Coverage Ratio (X) | 33.55 | 19.95 | 15.67 | 7.84 | 12.92 |
Interest Coverage Ratio (Post Tax) (X) | 22.84 | 13.47 | 11.19 | 2.61 | 7.94 |
Enterprise Value (Cr.) | 2398.91 | 1621.01 | 1546.18 | 724.65 | 469.93 |
EV / Net Operating Revenue (X) | 1.61 | 1.15 | 1.48 | 1.16 | 0.63 |
EV / EBITDA (X) | 12.75 | 12.44 | 18.66 | 27.92 | 10.25 |
MarketCap / Net Operating Revenue (X) | 1.60 | 1.14 | 1.46 | 1.13 | 0.60 |
Price / BV (X) | 4.03 | 3.45 | 3.99 | 2.00 | 1.28 |
Price / Net Operating Revenue (X) | 1.60 | 1.14 | 1.46 | 1.13 | 0.60 |
EarningsYield | 0.05 | 0.05 | 0.01 | 0.01 | 0.05 |
After reviewing the key financial ratios for Kingfa Science & Technology (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 101.17. This value is within the healthy range. It has increased from 67.22 (Mar 23) to 101.17, marking an increase of 33.95.
- For Diluted EPS (Rs.), as of Mar 24, the value is 101.17. This value is within the healthy range. It has increased from 67.22 (Mar 23) to 101.17, marking an increase of 33.95.
- For Cash EPS (Rs.), as of Mar 24, the value is 116.35. This value is within the healthy range. It has increased from 78.90 (Mar 23) to 116.35, marking an increase of 37.45.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 486.00. It has increased from 384.78 (Mar 23) to 486.00, marking an increase of 101.22.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 486.00. It has increased from 384.78 (Mar 23) to 486.00, marking an increase of 101.22.
- For Dividend / Share (Rs.), as of Mar 24, the value is 10.00. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 23) to 10.00, marking an increase of 10.00.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 1,228.45. It has increased from 1,159.08 (Mar 23) to 1,228.45, marking an increase of 69.37.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 155.39. This value is within the healthy range. It has increased from 107.56 (Mar 23) to 155.39, marking an increase of 47.83.
- For PBIT / Share (Rs.), as of Mar 24, the value is 140.21. This value is within the healthy range. It has increased from 95.89 (Mar 23) to 140.21, marking an increase of 44.32.
- For PBT / Share (Rs.), as of Mar 24, the value is 135.58. This value is within the healthy range. It has increased from 90.49 (Mar 23) to 135.58, marking an increase of 45.09.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 101.17. This value is within the healthy range. It has increased from 67.22 (Mar 23) to 101.17, marking an increase of 33.95.
- For PBDIT Margin (%), as of Mar 24, the value is 12.64. This value is within the healthy range. It has increased from 9.27 (Mar 23) to 12.64, marking an increase of 3.37.
- For PBIT Margin (%), as of Mar 24, the value is 11.41. This value is within the healthy range. It has increased from 8.27 (Mar 23) to 11.41, marking an increase of 3.14.
- For PBT Margin (%), as of Mar 24, the value is 11.03. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 11.03, marking an increase of 3.23.
- For Net Profit Margin (%), as of Mar 24, the value is 8.23. This value is within the healthy range. It has increased from 5.79 (Mar 23) to 8.23, marking an increase of 2.44.
- For Return on Networth / Equity (%), as of Mar 24, the value is 20.81. This value is within the healthy range. It has increased from 17.47 (Mar 23) to 20.81, marking an increase of 3.34.
- For Return on Capital Employeed (%), as of Mar 24, the value is 28.66. This value is within the healthy range. It has increased from 24.65 (Mar 23) to 28.66, marking an increase of 4.01.
- For Return On Assets (%), as of Mar 24, the value is 12.32. This value is within the healthy range. It has increased from 8.05 (Mar 23) to 12.32, marking an increase of 4.27.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.05. This value is within the healthy range. It has decreased from 0.08 (Mar 23) to 0.05, marking a decrease of 0.03.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.48. It has decreased from 1.49 (Mar 23) to 1.48, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 24, the value is 1.80. This value is within the healthy range. It has increased from 1.37 (Mar 23) to 1.80, marking an increase of 0.43.
- For Quick Ratio (X), as of Mar 24, the value is 1.20. This value is within the healthy range. It has increased from 0.83 (Mar 23) to 1.20, marking an increase of 0.37.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.11. This value is within the healthy range. It has increased from 3.84 (Mar 23) to 4.11, marking an increase of 0.27.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 33.55. This value is within the healthy range. It has increased from 19.95 (Mar 23) to 33.55, marking an increase of 13.60.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 22.84. This value is within the healthy range. It has increased from 13.47 (Mar 23) to 22.84, marking an increase of 9.37.
- For Enterprise Value (Cr.), as of Mar 24, the value is 2,398.91. It has increased from 1,621.01 (Mar 23) to 2,398.91, marking an increase of 777.90.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.61. This value is within the healthy range. It has increased from 1.15 (Mar 23) to 1.61, marking an increase of 0.46.
- For EV / EBITDA (X), as of Mar 24, the value is 12.75. This value is within the healthy range. It has increased from 12.44 (Mar 23) to 12.75, marking an increase of 0.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 1.14 (Mar 23) to 1.60, marking an increase of 0.46.
- For Price / BV (X), as of Mar 24, the value is 4.03. This value exceeds the healthy maximum of 3. It has increased from 3.45 (Mar 23) to 4.03, marking an increase of 0.58.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.60. This value is within the healthy range. It has increased from 1.14 (Mar 23) to 1.60, marking an increase of 0.46.
- For EarningsYield, as of Mar 24, the value is 0.05. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kingfa Science & Technology (India) Ltd:
- Net Profit Margin: 8.23%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 28.66% (Industry Average ROCE: 16.41%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 20.81% (Industry Average ROE: 12.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 22.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.2
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.2 (Industry average Stock P/E: 38.68)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.23%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Plastics - Plastic & Plastic Products | Dhun Building, 3rd Floor, Chennai (Madras) Tamil Nadu 600002 | cs@kingfaindia.com http://www.kingfaindia.com |
Management | |
---|---|
Name | Position Held |
Mr. Bo Jingen | Managing Director |
Mr. Doraiswami Balaji | Executive Director |
Mr. Wu Xiaohui | Non Exe.Non Ind.Director |
Mr. Dilip Dinkar Kulkarni | Independent Director |
Ms. Nilima Ramrao Shinde | Independent Director |
Mr. Ramachandran Sudhinder | Independent Director |
FAQ
What is the intrinsic value of Kingfa Science & Technology (India) Ltd?
Kingfa Science & Technology (India) Ltd's intrinsic value (as of 04 June 2025) is ₹2936.14 — 10.92% lower the current market price of 3,296.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 4,004 Cr. market cap, FY2025-2026 high/low of ₹3,954/1,810, reserves of 641 Cr, and liabilities of 1,063 Cr.
What is the Market Cap of Kingfa Science & Technology (India) Ltd?
The Market Cap of Kingfa Science & Technology (India) Ltd is 4,004 Cr..
What is the current Stock Price of Kingfa Science & Technology (India) Ltd as on 04 June 2025?
The current stock price of Kingfa Science & Technology (India) Ltd as on 04 June 2025 is 3,296.
What is the High / Low of Kingfa Science & Technology (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kingfa Science & Technology (India) Ltd stocks is ₹3,954/1,810.
What is the Stock P/E of Kingfa Science & Technology (India) Ltd?
The Stock P/E of Kingfa Science & Technology (India) Ltd is 26.2.
What is the Book Value of Kingfa Science & Technology (India) Ltd?
The Book Value of Kingfa Science & Technology (India) Ltd is 602.
What is the Dividend Yield of Kingfa Science & Technology (India) Ltd?
The Dividend Yield of Kingfa Science & Technology (India) Ltd is 0.30 %.
What is the ROCE of Kingfa Science & Technology (India) Ltd?
The ROCE of Kingfa Science & Technology (India) Ltd is 30.6 %.
What is the ROE of Kingfa Science & Technology (India) Ltd?
The ROE of Kingfa Science & Technology (India) Ltd is 23.2 %.
What is the Face Value of Kingfa Science & Technology (India) Ltd?
The Face Value of Kingfa Science & Technology (India) Ltd is 10.0.